ABSTRACT -Background and Objectives: To describe gender differences in a group of patients with first-episode psychotic in different aspects: socio-demographic features, characteristics of the phases prior to disease onset (premorbid and prodromic periods), clinical manifestation of psychotic symptoms and possible corresponding cognitive alterations after disease onset, using the age at onset of first psychotic episode as a control variable.
Introduction
"… Gender differences are an ideal window through which to look at the interplay of biological and psychosocial factors" 1 .
The study of gender differences in the psychotic spectrum disorders has given rise to a number of models which have been grouped in two different dimensions: clinical/psychosocial and neurobiological 2, 3 . The first refers to the expression of symptoms and social behaviour in schizophrenic patients. Males show a higher frequency of negative psychotic symptoms, whilst females, have a higher probability of showing affective symptoms 4, 5 ; usually, women with schizophrenia are more active and have a wider social network than affected men, who, in turn, are more passive and have social difficulties 6, 7 . The neurobiological dimension could include four hypotheses regarding gender differences in schizophrenia: a) the estrogen hypothesis postulates a protective effect by estrogens in the development of schizophrenia in women which could explain certain gender differences in the manifestation of the disease 8 . In women, estrogens could retard schizophrenia development up to menopause, which would explain its late onset 9 ; b) different sub-types of schizophrenia: postulates the existence of two distinct schizophrenias, masculine and feminine 10 , corresponding to different forms of expression of specific psychotic symptoms according to the gender of the patient rather than the existence two types of schizophrenic endophenotypes which are clearly differentiated. Castle et al. 11 , performed a study on a sample of patients with a first psychotic episode and identified three groups: a neurodevelopmental type (predominantly male), a schizoaffective type (almost entirely female) and a paranoid type (with equal sex ratio); c) early and late developmental models: both models postulate changes in the neurological development which predispose the appearance of schizophrenia, but in accordance with the early neurodevelopmental model, these anomalies start at the prenatal and neonatal stages 12 . On the other hand, the late neurodevelopmental ment includes: a socio-demographic questionnaire and an extensive battery of tests to assess premorbid/prodromic, clinical and cognitive characteristics. We perform mean differences tests to analyze continuous variables (non-parametric U-Mann-Whitney and t-Student test) and chi-square test for categorical variables (SPSS 16.0) .
Results: In the group of patients under 18 years, men showed higher scores in adjustment premorbid (U = 54.0, p = 0.050), more neurological soft signs (U = 31.0 p = 0.003), more negative psychotic symptoms (U = 48.5, p = 0.051) and worse insight (U = 30.0, p = 0.003) than women (after 8 weeks of psychotic episode onset).
Conclusions: We found gender differences in most of the variables analyzed when age at onset was controlled. These differences should be taken into account to learn more about the different types of onset of the disease, its prevention and possible improvements in therapeutic approach. Our findings suggest that younger men with an earlier onset of psychotic episode have more alterations in the stages prior to the onset of the disease supporting the neurodevelopmental hypothesis for gender differences.
model supports the hypothesis that these occur later in life, particularly during adolescence 13 ; d) and brain lateralization: this model attributes gender differences in schizophrenia to the differential hemispheric organization of the male and female brain since the latter is more symmetrically organized (less lateralized) than the male brain 14 .
These models do not necessarily contradict each other since they explain distinct aspects and periods in the disease progression. Häfner et al. 15, 16 , stated that the combination of both clinical/psychosocial and neurobiological models could explain gender differences in the expression of schizophrenia. Both clinicians and researchers have observed that males and females do not manifest psychotic spectrum disorders in the same way, since both differ in multiple aspects. In general, women tend to have a more benign form with less deterioration at presentation of schizophrenia.
Socio-demographic Variables
A consistent finding in the literature is the difference between men and women at age of onset of schizophrenia: males have an earlier age of onset compared to females by 3 -5 years 17, 18 , independently from the culture of the study group or the diagnostic classification used 3 . Castle et al. 19 , mention 3 peaks in the age at onset of schizophrenia with distinct distributions between women and men: an early peak which was more prominent in males, a middle peak which was more frequent in females and a third, late onset peak, which was nearly exclusively composed of females coinciding with the results from other studies 17, 18, 20 . Studies conducted on patients who presented a first psychotic episode 21, 22 continue to corroborate this idea. However, these results do not agree with other studies which do not found differences in age at onset between genders 23, 24 .
Throughout the last decades, other sociodemographic variables and their relationship with gender have been taken into account to explain the observed variability in the manifestation of schizophrenia. Various studies have demonstrated that the age of women at primary hospitalization was higher than for men 25 , that the development of the disease in women was less severe 26 and that premorbid competence was better in women than in men measured according to educational level, civil and work status 27 .
Studies by Mueser et al. 28 and Rabinowitz et al. 29 showed a lower frequency in alcohol, cannabis and other substance abuse in women than in men. In a study from Rabinowitz et al. 29 , in a sample of patients with a first psychotic episode, 17% of men and 6% of women had a moderate-severe grade of substance abuse.
Premorbid and prodromic variables
Classically, the premorbid period has been defined as the period preceding the start of clinical psychosis, whilst the prodromic period refers to the period in which the disease process starts in the absence of clear psychotic symptoms. Studies on the difference between genders during pre-psychotic periods have increased our knowledge regarding the variability in risk factors with respect to gender, the different characteristics in the transition process of psychosis and its later evolution and prognosis in both genders.
Numerous studies which have analyzed gender differences during the premorbid period in schizophrenic patients have shown a better premorbid adaptation in women than in men [30] [31] [32] , but their conclusions are not consistent 33, 34 . Such differences could be explained by a higher probability in the presentation of altered patterns in neurodevelopment in men than in women 35 .
Häfner et al. 9 explained that the better premorbid functioning (PF) in women with schizophrenia is due to social and academic factors: a later onset of the disease, an increased ability to maintain social relationships, to have finished their studies and to have an active life before the start of the first psychotic episode.
Studies in patients with a first psychotic episode have shown a possible relationship between the presence of Neurological Soft Signs (NSS) and the male gender 36 . NSS are minor ("soft") neurological abnormalities in sensory and motor performance identified by clinical examination. In a follow-up study by Madsen et al. 36 , a significant increase in the number of neurological abnormalities was observed in a group of males five years after the onset of the first psychotic episode. Nevertheless, results from studies with schizophrenia patients were not consistent with respect to the differences in gender and NSS. These studies showed increased NSS in patients with schizophrenia when compared to a healthy control group, however there is little evidence regarding gender differences with respect to the mean NSS demonstrated by patients 37, 38 .
In a study by Häfner 39 , which analyzed prodromic symptoms in a patient sample with a first psychotic episode, no gender differences were observed in the ten most frequent initial symptoms, except in worrying, which was significantly more frequent in women. In a sample of 231 patients with a first psychotic episode, Gutiérrez et al. 40 observed that the male group manifested the following prodromic symptoms with increased frequency: unusual perceptive experiences, deterioration in personal hygiene and psychosocial isolation. Nevertheless, due to difficulties in evaluating the prodromic period, as well as the variety of existing instruments, a number of inconsistencies in the methodology have been introduced in the scientific literature preventing a consensus in the study of prodromic symptoms.
Clinical Variables
The most reproducible data in the study of gender differences in the expression of psychotic symptoms has been the predominance of negative symptoms in men such as social withdrawal, blunted effect, poverty of speech and amotivation 35, [41] [42] [43] . In contrast, studies have shown that women manifest more affective symptoms, atypical and cyclical forms of psychosis as well as a higher incidence in the diagnosis of paranoid and disorganized subtypes 4, 44, 45 . Szymanski et al. 45 observed less illogical thinking but more anxiety, inappropriate affect and bizarre behaviour in women than men with first psychotic episode. Shtasel et al. 46 showed that men with schizophrenia showed more negative symptoms than women, however there were no gender differences with respect to positive psychotic symptoms. The studies of Gur et al. 47 and Lindamer et al. 48 , both studies confirmed that women experience less negative symptoms than men and that this is more evident in women who develop the disease later in life. Nevertheless, there are studies which did not demonstrate psychopathological differences between men and women suffering from schizophrenia 23, 49, 50 .
Traditionally it was considered that women with schizophrenia had better insight which in turn allowed them to use mental health services more than men. However, publications in the last years do not show any conclusive results regarding the relationship between gender and level of insight. On the other hand, a study with patients with a first psychotic episode, Mc Evoy et al. 51 demonstrated that multiple factors exist which contribute to having a good insight including late onset of the psychotic episode and female gender whilst earlier studies 52 go in the opposite direction and show that worse insight is associated with the female gender.
Cognitive function variables
Although a vast amount of work has been dedicated to study the cognitive function in schizophrenic patients, no consensus was reached with respect to gender differences. Some studies showed that men with schizophrenia have a greater cognitive deficit than women, especially in verbal processing; on the other hand; other studies conclude that women show worse cognitive function; whilst other studies failed to demonstrate any differences between the two groups.
Haas et al. 42 did not show any gender differences in cognitive functioning in patients with first psychotic symptoms, however, in patients with disease progression of 5 years or more, men showed a greater deficit in verbal tasks, which could indicate dysfunction in the left hemisphere. Various studies indicated that men with schizophrenia have more alterations in sustained attention, abilities in language, executive functions and intelligence than women 53, 54 . Nevertheless, other studies did not show any gender differences in cognitive functions between patients 55, 56 . On the other hand, others have found major alterations in the female group with schizophrenia on attention and conceptualization tasks 57 as well as on verbal memory, spatial memory and visual processing tasks 58 .
Aim
The aim of this study was to describe gender differences in a group of patients with first-episode psychotic in different aspects: socio-demographic features, characteristics of the phases prior to disease onset (premorbid and prodromic periods), clinical manifestation of psychotic symptoms and possible corresponding cognitive alterations after disease onset, using the age at onset of first psychotic episode as a control variable.
Methods

Sample
Our sample was composed of patients with a first psychotic episode selected in a consecutive manner. The patients were recruited when they were consulting in an adult mental health services at Sant Joan de Déu or the infant-juvenile services at the Hospital San Joan de Déu, either in a hospital or in a community psychiatric services. These centers belong to the metropolitan area and outskirts of Barcelona, taking into account a reference population of approximately 800,000 persons.
The inclusion criteria were: two or more psychotic symptoms (delirious ideas, hallucinations, disorganized speech, catatonic or disorganized behaviour and negative symptoms); age between 7 and 65 years; first psychiatric visit in any centre participating in the study; less than 6 months since the first contact to the medical service; and less than a year of symptoms' evolution. Patients diagnosed with mental retardation, craneoencephalic trauma or dementia were excluded from the study.
All selected individuals were informed of the objectives and methodology of this study by their psychiatrist or researcher and signed the required informed consent. In cases where the patients were minors, the informed consent was obtained from their parents or carers.
The study was approved by the Ethics and Research Comittee of the "Sant Joan de Déu".
Instruments of measurement
The socio-demographic characteristics of the sample (gender, mental health centre (community psychiatric services/ hospital), race, socioeconomic status, marital status, ages and level of education, and work status) including age at onset of illness, initial visit at a psychiatry services, history of substance abuse and family psychiatry history, were obtained via a clinical-sociodemographic questionnaire.
Information about premorbid and prodromic variables was collected using the following scales or interviews:
Premorbid Adjustment Scale (PAS) 59 . A 26-items scale, administrated by an researcher, which evaluates sociability and withdrawal, social relationships, adaptation to school and behavior at school in four periods: childhood, up to 11 years; early adolescence, 12-15 years; late adolescence, 16-18 years; and adult life, above 18 years; as well as social-sexual aspects after 15 years of age. The PAS also includes a section composed of 9 general items related to education, work, performance at work or at school, behaviour at school immediately before onset of psychosis, elevated level of independence on the family, high levels of social-personal adjustment, grade of interests in life and energy level. The total PAS score were in the range of 0.0 and 1.0, wherein higher scores represented lower levels of FP. The premorbid adjustment scale was completed using all available data, including clinical history data, interviews with patients and relatives. The scale was translated and its used was validated in the Spanish population 60 .
The present study is based on the results obtained from the research of Norman et al. 31 which find two factors: one showing academic PF (adaptation to and behaviour at school) and the second one showing a social PF (sociability and withdrawal; poor relationships and social-sexual adjustment). 61 : Structured interview which evaluates retrospectively the start of schizophrenia. The interview is composed of 5 sections for the collection of socio-demographic data relating to the patient, psychiatric symptoms starting from 12 years of age, prodromic symptoms and establishment of the disease as well as the quality of the information. In the present study, only the section comprising prodromic symptoms was used. This included 7 parts: perceptual disturbances (excluding hallucinations); hallucinations; subjective thought disturbances (i.e. thoughts being read, thought insertion); delusional ideas and delusions; cognitive deterioration; altered affect; behavioural and motor abnormalities; and dysfunctional language. The presence or absence of such symptoms was evaluated.
Interview for the Retrospective Assessment of the Onset of Schizophrenia (IRAOS)
Neurological Evaluation Scale (NES) 37 : a 26-item scale with three main subscales: sensory integration (SI), motor coordination (MC), sequencing of complex motor acts (SCMA) and an extra subscale that evaluates short-term memory, frontal release signs, and eye movement abnormalities ("others" subscale). Each item is rated from 0 to 2: 0 (no abnormality), 1 (mild, but definite im-pairment) and 2 (marked impairment). The higher the rating in total score, the higher the presence of neurological soft signs.
Information regarding clinical variables was obtained via the following scales or interviews:
Positive and Negative Syndrome Scale (PANSS) 62 , translated and validated by Peralta and Cuesta 63 . This scale is the most widely used scale of psychotic symptom evaluation. It measures 30 symptoms on a scale of 1-7, with higher scores indicating higher psychopathology. In this study, in order to analyze the date we have used four dimensions described by Villalta et al. 64 : positive, negative, affective, and excitative.
At the moment of inclusion of the patient, a retrospective evaluation of the symptoms was carried out in those cases where the psychiatrist reported a previous more severe symptomatology. A second evaluation was carried out 8 weeks later since the onset of episode.
Clinical Global Impression-Schizophrenia scale (ICG-ESQ). Determine the severity of the disease (scale from 1 to 7, from normal to higher severity) and the grade of improvement (scale from 1 to 9, from major improvement to non applicable) in four groups of schizophrenia symptoms (positive, negative, cognitive and depressive). A global severity score of the disease is also determinaded. Its use has been validated for use in the spanish population with the same purpose as the present study 65 . 66 is used to measure global functioning (clinical/social), where 0 represents severe dysfunction and 100 represents good functioning. 67 : a 20-item scale which assesses awareness of mental disorder, awareness of response to medication, awareness of social consequences of mental disorder, and awareness of specific symptoms of the illness. These items are rated according to a scale of 1 to 5, where a score of 1 is considered as being aware, a score of 3 is somewhat aware, and a score of 5 is unaware. For each symptom presented, a score is calculated based on the attribuition which the patient gave to the symptom (1 = Correct: symptom is due to a mental disorder; 3 = Partial: unsure, but can consider possibility that it is due to a mental disorder; 5= Incorrect: symptom is unrelated to a mental disorder). Higher scores on this scale indicate poor awareness. 68 : an 11-item scale which measures maniac symptoms. For adult patients the scale was administered by the researcher, whilst for adolescents, the self-administered version for parents (P-YMRS) was utilised. Some items were scored from 0-4 or 0-8 (in the case of items 5, 6, 8 and 9). The value of 0 means absence of symptoms whilst the highest value indicates the presence of the severe symptoms.
Global Assessment of Functioning Scale (GAF)
Scale for the Assessment of Unawareness of Mental Disorder (SUMD)
Young Mania Rating Scale (YMRS)
Cognitive assessment was performed by means of a neuropsychological battery designed to assess cognitive functions that the literature reports to be affected in psychotic disorders: attention, working memory, executive functioning and verbal memory. Table I summarises the neuropsychological tests which were used to measure each of these cognitive domains. To be able to calculate the total score for each of these domains, the direct score was transformed into a T-score (mean 50; SD = 10) and the mean of the scores according to each cognitive domain was calculated.
Statistical analysis
After verifying the hypothesis for normality using the Kolmogorov-Smirnov nonparametric test (p < 0.05) for all variables of the study, the gender differences were analyzed for each group of variables of interest.
The socio-demographic variables of patients were analyzed using a chi-square test for categorical variables and Student's test for continuous variables. For comparison of categorical variables with expected frequencies cells less than 5, the Fisher's exact test was used.
For the analysis of premorbid and prodromic variables, differences of the means were calculated for independent samples (Student's T-test) which allowed comparison the scores of PAS, NES and IRAOS with respect to gender.
Gender differences in clinical and cognitive variables were analyzed using differences of the means (Student's T-test) since all variables were quantitative and complied with the criteria for normality.
For the whole variables (socio-demographic, premorbid/prodromic, clinical and cognitive), a second analysis was carried out taking into account the age at onset of the psychotic episode. For this part of the study, the sample was divided into adults (> = 18 years) and adolescents (<18 years). The data were analyzed using the non-parametric UMann-Whitney test.
Analyses were carried out using SPSS statistical software package (version 16.0). All statistical tests were two-tailed, with p < 0.05 considered statistically significant.
Results
Up to now, 53 patients with a first psychotic episode have been evaluated. Males compose 49.1% (n = 26) of the sample with a mean age of 20.21 years (SD = 6.2). Patients which started the psychotic episode at less than 18 years of age, comprise 52.8% (n = 28) of the sample with their mean age being 16.14 (SD = 1.2). The subgroup which had the first psychotic episode in adulthood had a mean age of 24.76 years (SD = 6.3).
Gender differences with respect to socio-demographic characteristics and substance abuse Table II shows the gender differences and socio-demographic variables of the sample used in this study. Analysis of these results revealed significant differences only in two of the socio-demographic variables: failed school-course (χ 2 (1) = 6.526, p = 0.011) and work status (Fisher's Exact Test = 7.702, 0 = 0.050).
Women comprise 76.5% (n = 13) of the sample which did not fail any school-course, whilst from the repeater group, 61.1% (n = 22) are men. With respect to work status, 70% (n = 7) of patients who worked before the onset of the psychotic episode were men and from the patients who were unemployed 78.6% (n = 11) were women. No significant differences were observed between the groups of men and women with respect to the time elapsed until they had contact with mental health services (t = 0.650, p = 0.519), although the average number of days was higher in men and than in women (114 days against 89 days respectively).
With respect to substance abuse, there were significant differences between the genders in the consumption of cannabis and hallucinogenic substances (Table III) . Women composed 90% (n = 9) of sporadic consumers of cannabis, whilst 72.7% (n = 16) of daily consumers were men. In this sample there were no daily consumers of hallucinogenic substances, however 85.7% (n = 6) of sporadic consumers were men.
Patients belonging to families with previous psychotic disorders history comprise 28.3% (n = 13) of the sample, 17% (n = 9) of which are women. However, no significant differences were observed with respect to gender in family psychiatric history which includes disorders of the psychotic spectrum, affective disorders and others.
In a second analysis, no significant differences were observed between genders when the sample was divided into different age groups (<18 years: U = 88.0, p = 0.684; > = 18 years: U = 70.5, p = 0.720).
Gender difference in premorbid variables and prodromic symptoms
No significant gender differences were found in this sample either in global premorbid functioning or in its social and academic dimensions. However, when the effect of age at onset of psychotic episode was taken into account, significant differences were revealed: in patients younger than 18 years, men showed higher PF scores than women in total PAS (U = 54.0, p = 0.050) (Table IV) . In patients older than or equal to 18 years of age, women showed the highest scores, although this happened only in the social domain (U = 29.5, p = 0.018) ( Table V) . In patients younger than 18 years, significant differences in PF during early adolescent stage was observed (U = 38.0, p = 0.013), with males showing lower scores.
No significant differences between genders were observed in the presence of minor neurological signs (t = 0.394, p = 0.695). When the effect of age at onset of psychotic episode was taken into account, significant gender differences were observed: in the group younger than 18 years of age, men show higher number of minor neurological signs (U = 31.0, p = 0.003) and also higher total NES scores (U = 47.0, p = 0.056) (Table IV) than women; in patients 18 years and over, no significant differences were observed with respect to gender. Analysis of prodromic symptoms showed significant differences in gender in hallucinations, with a higher presence in women (t = -2.36, p = 0.017). When age at the beginning of psychotic episode was taken into account, this tendency was maintained in the age group younger than 18 years but not in the older group (> = 18 years) (U = 49.5, p = 0.052) (Tables IV y V). In this group there were significant differences in dysfunctional language (U = 31.0, p = 0.027) and tendencies in the variables for "subjective thought disturbance" (U = 33.0, p = 0.66) and "behavioural and motor abnormalities" (U = 39.0, p = 0.79) with higher scores obtained for males (Table V) .
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Gender differences in clinical variables
No significant gender differences were observed with respect to the presence and severity of psychotic symptoms at the onset of the psychotic episode. However, when age at onset was taken into account, gender differences were observed: men < 18 years showed an increased severity in negative psychotic symptoms with respect to women, both in the acute phase (although significant differences were not observed: males = 15.63; females = 13.66; p = 0.530) and during the stable phase, showing a significant tendency (U = 48.5, p = 0.051) (Table IV) . In the > = 18 years age group, a tendency in gender differences with respect to excitative symptoms was observed in the acute phase with men showing a higher score (U = 42.0, p = 0.055). On the Young scale, significant gender differences were observed only in the group > = 18 years, with males showing higher scores than women (U = 34.0, p = 0.014) ( Table V) .
As other clinical variables, gender differences were observed if age at onset of the disease was taken into account, regarding to the awareness of the disease. In the group which started the episode at an earlier age, awareness of the symptoms of the disease was worse in males (U = 30.0, p = 0.003) (Table IV) . On the other hand, in the older age group the opposite result was observed, with women scoring lower on the subscale for symptom awareness of SUMD, although this difference was not significant (U = 42.5, p = 0.088) ( Table V) . No significant differences between genders were observed in the attribution of symptoms.
No other significant differences were observed between genders in the other clinical variables studied (GAF and CGI).
Gender differences in cognitive functioning
In the analysis of cognitive domains, significant gender differences were observed only with respect to verbal memory (t = 2.49, p = 0.017) with worse scores obtained by women. These differences were still observed after subdividing the sample into age groups according to age at onset of first psychotic episode.
Discussion
Gender differences with respect to psychotic disorders are an important factor in the understanding of the manifestation and development of the disease. Even though in the last decades this was an intensively studied aspect, controversial results were obtained from the different studies performed.
In line with Angermeyer et al. 27 , we observed that women have a higher educational competence than men. On the other hand, our results do not coincide with these authors with respect to labour competence, with men being in a better situation before onset of the disease. In the last decades, several studies have been published supporting the hypothesis that no gender differences existed with respect to age at onset of schizophrenia 23, 24 . Indeed our results are in line with these studies. One of the limitations that could account for this difference in results across the literature is the limited age range for inclusion in the studies, which would not permit a representative sample of the population as a whole. On the other hand, tobacco, alcohol and cannabis are frequently used by schizophrenia patients 69, 70 , as confirmed by the sample in this study. We observed a higher frequency of cannabis consumers among younger men with a first psychotic episode. This result has been described by other authors 71, 72 .
The gender differences observed in the premorbid clinical variables studied are due to the effect of age. These differences are in line with a model for neurodevelopment which indicates that subtle abnormalities could be observed already at PF, especially in early adolescence and a higher number of minor neurological symptoms in persons who later develop the disease. Such aspects would be more frequent in male patients who start a psychotic episode early.
As mentioned previously, there is considerable controversy regarding gender differences with respect to the presentation of symptoms in psychotic disorder spectrum. With respect to positive psychotic symptoms, a large number of studies have reached the conclusion that both men and women experience the same level of positive symptoms 23, 46 , although certain symptoms such as auditory hallucinations and persecutory delusions are more frequent in women 44 . The analysis regarding prodromic symptoms in our sample comes to similar conclusions, with women showing an early onset of the disease presenting a higher frequency of subclinical senso-perceptive disturbance. Instead, the group of younger men had worse dysfunctional language than women before the onset of psychotic episode.
When symptoms of the first psychotic episode were taken into account, our results were in line with studies that did not find psychopathological differences between men and women with schizophrenia 23, 49, 50 . However, the differences found refer to the course of the first episode and not to the expression of initial symptoms. The presence of a higher severity in negative psychotic symptoms and poor awareness of disease, after 8 weeks of evolution of the episode, in the group of males younger than 18 years could suggest the presence of a subpopulation which is more resistant to therapeutic interventions and with worse prognosis. Nevertheless, in line with the results from Cuesta & Peralta 52 , women in our sample with a later onset of the disease show less awareness of symptoms.
Although a large number of articles has been dedicated to cognitive functioning in patients with schizophrenia, no consensus was reached regarding the observed gender differences. This is mostly due to the variability of instruments of measure utilised to evaluate the different cognitive domains. In line with results by Haas et al. 42 , no significant differences in gender were observed in executive function, attention and working memory in patients with first psychotic episode. Without doubt, the differences in verbal memory, with men having better capacity, add more data to the divergent results found in the scientific literature. However, we are currently conducting a one year follow-up study of first psychotic episodes which will produce more data regarding questions that still need to be clarified in the literature.
Limitations
Some limitations of the present study are related to the measurement instruments used: Premorbid Adjustment Scale (PAS) and Interview for the Retrospective Assessment of the Onset of Schizophrenia (IRAOS) are instruments for retrospective assessment, in which some information could be inaccurate as it relies on the patients' or family members' memory.
The size of the sample is another limitation for this study and does not permit the extrapolation of the data obtained to the general population. It also makes it difficult to stratify the sample to study and compare different groups (it is necessary to use non parametric tests).
The absence of a control group does not allow to performance a comparison between both populations, health people and patients with a psychotic episode in relation to the premorbid and prodromic variables.
Other limitation is related to patients that have an insidious onset of psychotic episode and not consult to mental health services included in our study. For this reason, not all the first psychotic episodes could be represented in our sample.
Finally, the absence of a control for pharmacological treatment group could influence the analysis of certain variables as well as the symptoms after 8 weeks of evolution of the episode or cognitive functioning. It is a factor which will be taken into account in future analyses. Nevertheless, this limitation is not considered to invalidate the overall conclusions which have been reached in this study.
Conclusion
The most relevant conclusions from our study are the following: -Women have a higher educational competence than men. In return, men show a higher labour competence than women before onset of the disease.
-No significant differences in gender were observed with respect to onset of the psychotic episode.
-Men are more frequently daily consumers of cannabis whilst women are usually sporadic users.
-Males who started the psychotic episode earlier showed more alterations in premorbid functioning, especially in early adolescence, and a higher number of neurological soft signs.
-Women in early onset showed a higher frequency of senso-perceptive subclinical disturbance (hallucinations) in the prodromic phase.
-Males younger than 18 years show negative psychotic symptoms which are more severe and poorer awareness than females, after 8 weeks of onset the first psychotic episode.
-No gender differences were observed in executive functioning, attention and working memory, although this was different with respect to verbal memory with men having a higher performance.
-Age is an important variable to be considered in future studies about gender differences in psychotic disorders.
The conclusions are important in light of the idea that men and women suffering from schizophrenia show features, characteristics and pecularities typical of their gender. These characteristics should be taken into account to learn more about the different types of onset of the disease, its prevention and possible improvements in therapeutic approach with respect to gender. Finally, it is important to mention that a large part of the discovered gender differences are within the context of a neurodevelopmental model and the existence of alterations in the stages prior to the onset of the disease which predispose its appearance.
